Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence
Year: 2020
Type: article
Abstract: Yorkie, a transcriptional coactivator of the Hippo pathway. TAZ has been suggested to function as a regulator that modulates the expression of cell proliferation and anti-apoptotic genes in order to stimulate cell proliferation. TAZ has also been associated with a poor prognosis in several cancers, including breast cancer. However, the physiological role of TAZ in tumorigenesis remains unclear. We herein demonstrated that TAZ negatively regulated the activity of the tumor suppressor p53. The overexpression of TAZ down-regulated p53 transcriptional activity and its downstream gene expression. In contrast, TAZ knockdown up-regulated p21 expression induced by p53 activation. Regarding the underlying mechanism, TAZ inhibited the interaction between p53 and p300 and suppressed the p300-mediated acetylation of p53. Furthermore, TAZ knockdown induced cellular senescence in a p53-dependent manner. These results suggest that TAZ negatively regulates the tumor suppressor functions of p53 and attenuates p53-mediated cellular senescence.
Source: Cells
DOI: 10.3390/cells9010171
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,112
Awards: Mechanism of conversion of TGF-beta from tumor suppressor to malignant factor by post-translational modification control, Molecular basis of the oncogenic effects of novel oncogene candidates, TRB family members, Development of anticancer drugs based on a new oncogenic mechanism of a novel oncogene candidate molecule TRB1, The Role of Blood Fibrinolytic Factor Plasmin Activity in Manipulating Macrophage-mediated Mechanisms of Atherosclerosis Promotion, Identification of a novel deubiquitinating enzyme that controls epithelial-mesenchymal transition and its application to cancer treatment.
OpenAlex ID: W3000466000
